InvestorsHub Logo

MontanaState83

05/02/15 10:47 PM

#48662 RE: jessellivermore #48661

JL - Always appreciate your insights. Sure hope you're right!

couldbebetter

05/03/15 12:07 AM

#48665 RE: jessellivermore #48661

Appreciate the knowledgeable explanation. I am hoping for a 50% reduction in cardiovascular events as the dosage of Vascepa is more than 2 times that of Jellis and the population is much more ill. No plans to sell any shares for what may be a very long time. Today I went over many of your older posts and there are a great many gems. You should compile them and write a book with a title of something like "What You Should Know About Pure EPA to Reduce Inflammation and Live Longer." Heck, maybe you could also have a flyer as a companion piece, and your book would be more in-depth information. You certainly are an exceptionally gifted writer especially your use of analogies. You could even plan an updated version once Reduce-It results come out. Imagine some of the chapter titles, Pure EPA and scar healing, a perspective from a plastic surgeon, EPA and Gum Disease,etc. If you wrote such a book I would want to have several copies to give to a few people who would benefit from the knowledge. How about an appearance on Dr. Oz. Or, a sub-title: A Book For Doctors and Their Patients written by a Doctor for His Patients. Hmmm, I may have had a little too much coffee tonight!

rosemountbomber

05/03/15 5:39 AM

#48666 RE: jessellivermore #48661

I wonder what this Dwarvish fellow used to hypothesis (sounds like he reached a conclusion) that EPA is not dose dependent past a certain threshold. If it was based on Jelis the only thing would be the all-cause mortality (which was the same in both groups), hopefully not the fact that some of the efficacy of EPA was deemed non-significant --- which you correctly described as being a result of the underpowered nature of the study.

I know of a few things that once they reach a saturation level or threshold provide no further benefit but by far and away most substances are dose dependent.